Is Buying Counterpath Corporation (NASDAQ:CPAH) Here Good Idea?

January 16, 2018 - By Stephen Andrade

 Is Buying Counterpath Corporation (NASDAQ:CPAH) Here Good Idea?

The stock of Counterpath Corporation (NASDAQ:CPAH) registered a decrease of 20% in short interest. CPAH’s total short interest was 1,600 shares in January as published by FINRA. Its down 20% from 2,000 shares, reported previously. With 5,500 shares average volume, it will take short sellers 0 days to cover their CPAH’s short positions. The short interest to Counterpath Corporation’s float is 0.07%.

The stock increased 11.37% or $0.68 during the last trading session, reaching $6.66. About 537,170 shares traded or 156.70% up from the average. CounterPath Corporation (NASDAQ:CPAH) has declined 12.94% since January 16, 2017 and is downtrending. It has underperformed by 29.64% the S&P500.

CounterPath Corporation designs, develops, markets, and sells software applications and related services in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company has market cap of $35.06 million. The companyÂ’s software applications and related services enable enterprises and telecommunication service providers to deliver voice, video, and messaging and collaboration functionality over their Internet protocol and based networks. It currently has negative earnings. The Company’s products include Bria softphone suite, which enables clients and business users to make voice over Internet protocol audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and X-Lite, a standards VoIP softphone application that runs on desktop computers.

Another recent and important CounterPath Corporation (NASDAQ:CPAH) news was published by which published an article titled: “KMG Chemicals, Black Hills, CounterPath, eGain and SeaChange International …” on December 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: